United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1282_1245c4fb-1cb1-42f8-962d-f059c222ed3f
- Product NDC
- 71335-1282
- Form
- TABLET
- Composition / generic term
- Naproxen Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190101
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET in 1 BOTTLE (71335-1282-1) · 71335-1282-1
- 30 TABLET in 1 BOTTLE (71335-1282-2) · 71335-1282-2
- 40 TABLET in 1 BOTTLE (71335-1282-3) · 71335-1282-3
- 50 TABLET in 1 BOTTLE (71335-1282-4) · 71335-1282-4
- 60 TABLET in 1 BOTTLE (71335-1282-5) · 71335-1282-5
- 14 TABLET in 1 BOTTLE (71335-1282-6) · 71335-1282-6
- 100 TABLET in 1 BOTTLE (71335-1282-7) · 71335-1282-7
- 90 TABLET in 1 BOTTLE (71335-1282-8) · 71335-1282-8
- 24 TABLET in 1 BOTTLE (71335-1282-9) · 71335-1282-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →